Quick Takeaways
- Jeff Fairman has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $22,935,618.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jeff Fairman
- Location
- San Carlos, CA
- Summary
- The estimated net worth of Jeff Fairman is at least $22,935,618 dollars as of 04 Jan 2023. Jeff Fairman is the VP, Research of Vaxcyte, Inc. and owns shares of Vaxcyte, Inc. (PCVX) stock worth about $22.94M.
- Signature
- Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jeff Fairman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Vaxcyte, Inc. ($22,935,618).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jeff Fairman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | VP, Research | $22,935,618 | 30 Dec 2022 |
Insider Transactions Reported by Jeff Fairman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.